IMBALANCED ACTIVATING AND INHIBITORY RECEPTORS ON CD56DIM NATURAL KILLER CELLS PREDICTS POOR OUTCOMES IN ACUTE MYELOID LEUKEMIA AFO Costa; V Kuznetsova; LO Marani; IA Lopes; LS Binelli; PS Scheucher; JL Schiavinato; MIA Madeira; KBB Pagnano; BK Duarte; ABF Glória; EM Rego; F Traina; R Welner; LL Figueiredo-Pontes;

NATURAL KILLER CELLS PHENOTYPE CORRELATES WITH TYROSINE KINASE INHIBITORS TREATMENT RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS LS Binelli; AFO Costa; LO Marani; IA Lopes; F Traina; LC Palma; PMM Garibaldi; LL Figueiredo-Pontes;

FLT3-ITD MUTATION PROMOTES LEUKEMIC DIFFERENTIATION TOWARDS AN IMMATURE CYTOTOXIC STAGE AG de Carvalho; M Medeiros; CAB Garcia; LS Binelli; AFO Costa; BL Adjafre; LO Marani; PS Scheucher; JLS Schiavinato; MIA Madeira; JA de Paula; KBB Pagnano; BKL Duarte; ABF Glória; EC Nunes; M Higashi; WFS Junior; F Traina; EM Rego; LL de Figueiredo-Pontes;